XML 76 R61.htm IDEA: XBRL DOCUMENT v3.22.1
COMMITMENTS AND CONTINGENCIES (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 01, 2022
Mar. 31, 2022
USD ($)
patent
Oct. 31, 2021
patent
Apr. 30, 2020
agreement
plaintiff
Dec. 31, 2019
USD ($)
opposingParty
patent
Mar. 31, 2022
USD ($)
lawsuit
plaintiff
Dec. 31, 2021
USD ($)
Dec. 31, 2016
party
Loss Contingencies [Line Items]                
Accrued litigation | $   $ 0       $ 0 $ 1,250,000,000  
Number of patents challenged, scenario two         2      
Number of patents challenged, scenario one         4      
Number of additional patents allegedly infringed     2          
Number of patents challenged   3            
Number of patents   5            
ViiV Healthcare Company                
Loss Contingencies [Line Items]                
Settlement payment | $           $ 1,250,000,000    
Royalty percentage on future sales 3.00%              
Loss related to litigation | $             $ 1,250,000,000  
Juno Therapeutics, Inc. and Sloan Kettering Cancer Center                
Loss Contingencies [Line Items]                
Damages awarded | $         $ 585,000,000      
Running royalty rate from October 2017         27.60%      
Enhancement rate on past damages       50.00%        
Running royalty rate on future sales       27.60%        
Pre-Exposure Prophylaxis                
Loss Contingencies [Line Items]                
Number of material transfer agreements | agreement       4        
European Patent Claims 2024 Expiration                
Loss Contingencies [Line Items]                
Number of parties appealed | opposingParty         2      
European Patent Claims 2026 Expiration                
Loss Contingencies [Line Items]                
Number of parties appealed | opposingParty         3      
European Patent Claims 2032 Expiration                
Loss Contingencies [Line Items]                
Number of parties appealed | opposingParty         3      
European Patent Claims 2027 Expiration                
Loss Contingencies [Line Items]                
Number of parties appealed | opposingParty         2      
Number of parties filing opposition | party               3
Product Liability                
Loss Contingencies [Line Items]                
Number of class action lawsuits | lawsuit           1    
Number of plaintiffs involved | plaintiff           27,000    
Qui Tam                
Loss Contingencies [Line Items]                
Number of plaintiffs involved | plaintiff       2